Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

Source:http://linkedlifedata.com/resource/pubmed/id/19584651

Download in:

View as

General Info

PMID
19584651